Table 5.
Mapping drivers and obstacles onto innovation attributes that facilitate and accelerate adoption.
| Innovation attributes | Drivers | Obstacles |
|---|---|---|
| Relative advantage | D1 - Superior scientific understanding D2 - New applications D3 - Reduced cost & increased efficiency D4 - Scientific and technological advances D5 - Belief in the potential of omics D6 - Stakeholder commitment & investment D7 - Reduced animal use D8 - Numerous untested chemicals |
O1 - Insufficient validation O2 - Complexity of interpretation O5 - Difficulty of coordination O7 - High level of required investment O8 - Lack of organizational support O9 - Uncertain economic benefits O10 - Inadequacy for some applications |
| Compatibility | D6 - Stakeholder commitment & investment D9 - Enabling laws & regulations D10 - Accessibility of capabilities & resources D11 - International collaboration & harmonization |
O1 - Insufficient validation O2 - Complexity of interpretation O3 - Lack of standardization O4 - Lack of expertise O5 - Difficulty of coordination O8 - Lack of organizational support |
| Simplicity | D6 - Stakeholder commitment & investment D10 - Accessibility of capabilities & resources D11 - International collaboration & harmonization |
O2 - Complexity of interpretation O3 - Lack of standardization O4 - Lack of expertise O5 - Difficulty of coordination O8 - Lack of organizational support |
| Trialability | D6 - Stakeholder commitment & investment D10 - Accessibility of capabilities & resources |
O1 - Insufficient validation O5 - Difficulty of coordination O8 - Lack of organizational support |
| Observability | D6 - Stakeholder commitment & investment D10 - Accessibility of capabilities & resources |
O1 - Insufficient validation O5 - Difficulty of coordination O8 - Lack of organizational support |